Dr. Stephen Conway, M.D

NPI: 1104866524
Total Payments
$11,972
2024 Payments
$17.71
Companies
62
Transactions
710
Medicare Patients
2,459
Medicare Billing
$331,246

Payment Breakdown by Category

Food & Beverage$11,559 (96.6%)
Other$412.85 (3.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $11,559 687 96.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $412.85 23 3.4%

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $1,533 70 $0 (2023)
Biogen, Inc. $1,020 69 $0 (2023)
Teva Pharmaceuticals USA, Inc. $804.23 81 $0 (2023)
Novartis Pharmaceuticals Corporation $684.53 53 $0 (2023)
AbbVie Inc. $674.59 34 $0 (2023)
Supernus Pharmaceuticals, Inc. $418.55 28 $0 (2022)
Acorda Therapeutics, Inc $412.85 23 $0 (2020)
Alexion Pharmaceuticals, Inc. $370.51 12 $0 (2023)
Allergan, Inc. $341.05 28 $0 (2020)
Amneal Pharmaceuticals LLC $322.76 18 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $17.71 1 MDD US Operations, LLC ($17.71)
2023 $2,336 133 Novartis Pharmaceuticals Corporation ($337.14)
2022 $1,461 74 ABBVIE INC. ($248.25)
2021 $1,420 80 Biogen, Inc. ($165.23)
2020 $1,130 74 Allergan, Inc. ($252.78)
2019 $1,921 107 GENZYME CORPORATION ($269.37)
2018 $1,776 102 GENZYME CORPORATION ($453.69)
2017 $1,911 139 GENZYME CORPORATION ($411.44)

All Payment Transactions

710 individual payment records from CMS Open Payments — Page 1 of 29

Date Company Product Nature Form Amount Type
02/08/2024 MDD US Operations, LLC Gocovri (Drug) Food and Beverage In-kind items and services $17.71 General
Category: AMANTADINE
12/21/2023 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $9.38 General
Category: Neurology
12/21/2023 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $1.53 General
Category: Neurology
12/15/2023 PFIZER INC. NURTEC ODT (Drug) Food and Beverage In-kind items and services $19.58 General
Category: PAIN
12/09/2023 AbbVie Inc. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $27.23 General
Category: NEUROSCIENCE
12/08/2023 Amylyx Pharmaceuticals, Inc. RELYVRIO (Drug) Food and Beverage In-kind items and services $23.72 General
Category: NEUROLOGY
12/07/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $15.04 General
Category: Neuroscience
12/07/2023 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $13.08 General
Category: NEUROLOGY
11/30/2023 Biogen, Inc. VUMERITY (Drug) Food and Beverage In-kind items and services $24.82 General
Category: Neurology
11/18/2023 Azurity Pharmaceuticals, Inc. Horizant (Drug) Food and Beverage Cash or cash equivalent $21.14 General
Category: Sleep
11/17/2023 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $7.35 General
Category: PAIN
11/14/2023 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $16.98 General
Category: NEUROLOGY
11/14/2023 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $4.40 General
Category: Neurology
11/11/2023 MDD US Operations, LLC GOCOVRI (Drug) Food and Beverage Cash or cash equivalent $19.34 General
Category: NEUROLOGY
11/09/2023 Neurocrine Biosciences, Inc. Ongentys (Drug), INGREZZA Food and Beverage In-kind items and services $25.76 General
Category: Neuropsychiatry
11/08/2023 GENZYME CORPORATION Food and Beverage In-kind items and services $20.60 General
11/07/2023 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $19.47 General
Category: Central Nervous System
11/02/2023 Teva Pharmaceuticals USA, Inc. AJOVY (Biological) Food and Beverage In-kind items and services $19.82 General
Category: Central Nervous System
10/27/2023 EMD Serono, Inc. MAVENCLAD (Drug) Food and Beverage Cash or cash equivalent $15.75 General
Category: Neurology
10/26/2023 Alexion Pharmaceuticals, Inc. SOLIRIS (Biological) Food and Beverage In-kind items and services $22.44 General
Category: Rare Disease
10/24/2023 Lilly USA, LLC AMYVID (Drug) Food and Beverage In-kind items and services $25.65 General
Category: Neuroscience
10/19/2023 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $16.58 General
Category: Neurology
10/19/2023 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $4.97 General
Category: PAIN
10/18/2023 UCB, Inc. Food and Beverage In-kind items and services $27.35 General
10/16/2023 Azurity Pharmaceuticals, Inc. Horizant (Drug) Food and Beverage Cash or cash equivalent $19.86 General
Category: Sleep

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 642 818 $449,139 $87,434
2022 11 635 797 $420,835 $88,752
2021 11 602 738 $362,984 $82,343
2020 11 580 705 $335,172 $72,716
Total Patients
2,459
Total Services
3,058
Medicare Billing
$331,246
Procedure Codes
45

All Medicare Procedures & Services

45 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2023 166 268 $88,440 $22,671 25.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 154 211 $48,741 $21,054 43.2%
95909 Nerve conduction, 5-6 studies Office 2023 62 62 $67,518 $7,007 10.4%
95910 Nerve conduction, 7-8 studies Office 2023 42 46 $66,792 $6,775 10.1%
95911 Nerve conduction, 9-10 studies Office 2023 35 35 $63,525 $6,410 10.1%
95913 Nerve conduction, 13 or more studies Office 2023 20 20 $48,400 $4,669 9.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 25 29 $8,323 $4,205 50.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 50 55 $7,975 $3,734 46.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 25 25 $8,725 $3,483 39.9%
95912 Nerve conduction, 11-12 studies Office 2023 14 14 $30,492 $2,951 9.7%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 16 16 $6,064 $2,771 45.7%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 33 37 $4,144 $1,707 41.2%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2022 161 278 $91,410 $24,982 27.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 152 190 $43,890 $19,454 44.3%
95909 Nerve conduction, 5-6 studies Office 2022 95 99 $107,811 $11,691 10.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 38 40 $11,480 $6,161 53.7%
95910 Nerve conduction, 7-8 studies Office 2022 36 37 $53,724 $5,925 11.0%
95912 Nerve conduction, 11-12 studies Office 2022 24 24 $52,272 $5,370 10.3%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 26 26 $9,854 $4,913 49.9%
95911 Nerve conduction, 9-10 studies Office 2022 19 19 $34,485 $3,579 10.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 22 22 $7,678 $2,967 38.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 39 39 $5,655 $2,569 45.4%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 23 23 $2,576 $1,140 44.2%
95886 Needle measurement and recording of electrical activity of muscles of arm or leg complete study Office 2021 144 236 $73,620 $21,777 29.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 146 183 $39,879 $18,782 47.1%

About Dr. Stephen Conway, M.D

Dr. Stephen Conway, M.D is a Neurology healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104866524.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Conway, M.D has received a total of $11,972 in payments from pharmaceutical and medical device companies, with $17.71 received in 2024. These payments were reported across 710 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($11,559).

As a Medicare-enrolled provider, Conway has provided services to 2,459 Medicare beneficiaries, totaling 3,058 services with total Medicare billing of $331,246. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Hartford, CT
  • Active Since 06/07/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1104866524

Products in Payments

  • AUBAGIO (Drug) $910.32
  • LEMTRADA (Drug) $618.55
  • COPAXONE (Drug) $471.69
  • RYTARY (Drug) $462.67
  • UBRELVY (Drug) $408.52
  • TYSABRI (Biological) $369.20
  • TECFIDERA (Drug) $367.25
  • QULIPTA (Drug) $358.85
  • KESIMPTA (Drug) $310.08
  • NURTEC ODT (Drug) $291.82
  • GOCOVRI (Drug) $275.80
  • NUEDEXTA (Drug) $232.98
  • TROKENDI XR (Drug) $229.53
  • AJOVY (Biological) $221.17
  • Gamunex-C (Biological) $215.21
  • AMPYRA (Drug) $213.75
  • INBRIJA (Drug) $199.10
  • SOLIRIS (Drug) $196.17
  • Briviact (Drug) $184.86
  • UPLIZNA (Drug) $168.19

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Hartford